Abstract:Background : The vascular endothelium plays a fundamental role in the health and disease of the cardiovascular system. However, the molecular mechanisms regulating endothelial homeostasis remain incompletely understood. CCN3, a member of the CCN (Cyr61, Ctgf, Nov) family of cell growth and differentiation regulators, has been shown to play an important role in numerous cell types. While CCN3 expression in endothelial cells has been described, its function in this cell type has yet to be elucidated. Methods and Results : A detailed immunohistochemical analysis of CCN3 expression in mouse tissues revealed robust immunoreactivity in the endothelium of large arteries, small resistance vessels, as well as veins. Likewise, CCN3 expression is observed in cultured human endothelial cells derived from a variety of vascular beds. CCN3 expression in human umbilical vein endothelial cells (HUVECs) is transcriptionally induced by laminar shear stress (LSS) by ~27-fold. Similarly, treatment of HUVEC with HMG CoA-reductase inhibitors (statins) induced CCN3 expression by ~32-fold. A combination of promoter deletion and mutational analyses coupled with chromatin immuno-precipitation studies identified the Kruppel-like factor 2 as a direct regulator of CCN3 expression. In contrast to LSS, proinflammatory cytokines such as TNF α reduced CCN3 expression. Functionally, adenoviral overexpression of CCN3 in HUVEC markedly inhibited the cytokine-mediated induction of VCAM-1. Consistent with this observation, CCN3 overexpression significantly reduced monocyte adhesion. Conversely, siRNA mediated “knockdown” of CCN3 protein in HUVECs resulted in enhancement of cytokine-induced VCAM-1 expression. Concordant effects were observed on monocyte adhesion. Mechanistically, gain and loss-of-function studies demonstrate that CCN3 negatively regulates NF- κ B activity by reducing its translocation into nucleus and DNA binding to VCAM-1 promoter, suggesting that CCN3’s anti-inflammatory effects occur secondary to inhibition of NF- κ B nuclear accumulation. Conclusions: This study identifies CCN3 as a novel regulator of endothelial proinflammatory activation.

Decrease of Intracellular Chloride Concentration Promotes Endothelial Cell Inflammation by Activating Nuclear Factor-κB Pathway

Reduced Intracellular Chloride Concentration Impairs Angiogenesis by Inhibiting Oxidative Stress-Mediated VEGFR2 Activation

ClC-3 Chloride Channel/antiporter Defect Contributes to Inflammatory Bowel Disease in Humans and Mice

CLIC1 Inhibition Attenuates Vascular Inflammation, Oxidative Stress, and Endothelial Injury

Zc3h12c Inhibits Vascular Inflammation By Repressing Nf-Kappa B Activation And Pro-Inflammatory Gene Expression In Endothelial Cells

Zc3h12c inhibits vascular inflammation by repressing NF-κB activation and pro-inflammatory gene expression in endothelial cells

Abrogating ClC-3 Inhibits LPS-induced Inflammation via Blocking the TLR4/NF-κB Pathway

ClC-3 Promotes Angiotensin II-induced Reactive Oxygen Species Production in Endothelial Cells by Facilitating Nox2 NADPH Oxidase Complex Formation

Increased Intracellular Cl− Concentration Promotes Ongoing Inflammation in Airway Epithelium

Reduction of Intracellular Chloride Concentration Promotes Foam Cell Formation

Abstract 4954: A Novel Role of CCN3 in Regulating Endothelial Inflammation

The Monocyte-Derived Exosomal CLMAT3 Activates the CtBP2-p300-NF-B Transcriptional Complex to Induce Proinflammatory Cytokines in ALI

A novel role of CCN3 in regulating endothelial inflammation

Increased intracellular Cl − concentration mediates neutrophil extracellular traps formation in atherosclerotic cardiovascular diseases

Low Chloride–Regulated ClC-5 Contributes to Arterial Smooth Muscle Cell Proliferation and Cerebrovascular Remodeling

Regulation Of Intracellular Cl- Concentration Through Volume-Regulated Clc-3 Chloride Channels In A10 Vascular Smooth Muscle Cells

Inhibition of NK Cell Cytotoxicity by Tubular Epithelial Cell Expression of Clr-b and Clr-f

Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signaling

Inhibition of Orai1-mediated Ca2+ Entry Limits Endothelial Cell Inflammation by Suppressing Calcineurin-Nfatc4 Signaling Pathway

ClC-3 Deficiency Prevents Apoptosis Induced by Angiotensin II in Endothelial Progenitor Cells Via Inhibition of NADPH Oxidase

ClC-2 knockdown prevents cerebrovascular remodeling via inhibition of the Wnt/β-catenin signaling pathway